108.68 USD
+0.08
0.07%
At close Apr 30, 4:00 PM EDT
After hours
105.50
-3.18
2.93%
1 day
0.07%
5 days
0.18%
1 month
-2.26%
3 months
0.40%
6 months
-1.28%
Year to date
6.17%
1 year
29.92%
5 years
191.84%
10 years
244.80%
 

About: Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

Employees: 12,694

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

50% more call options, than puts

Call options by funds: $427M | Put options by funds: $284M

46% more first-time investments, than exits

New positions opened: 162 | Existing positions closed: 111

1% more funds holding

Funds holding: 1,524 [Q3] → 1,540 (+16) [Q4]

0.24% more ownership

Funds ownership: 66.55% [Q3] → 66.79% (+0.24%) [Q4]

4% less capital invested

Capital invested by funds: $41.6B [Q3] → $40.1B (-$1.47B) [Q4]

13% less repeat investments, than reductions

Existing positions increased: 495 | Existing positions reduced: 572

23% less funds holding in top 10

Funds holding in top 10: 30 [Q3] → 23 (-7) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$95
13%
downside
Avg. target
$105
3%
downside
High target
$124
14%
upside

7 analyst ratings

positive
14%
neutral
71%
negative
14%
Morgan Stanley
Nigel Dally
64% 1-year accuracy
7 / 11 met price target
8%downside
$100
Equal-Weight
Maintained
10 Apr 2025
UBS
Brian Meredith
75% 1-year accuracy
27 / 36 met price target
5%upside
$114
Neutral
Maintained
2 Apr 2025
Piper Sandler
John Barnidge
47% 1-year accuracy
22 / 47 met price target
14%upside
$124
Overweight
Maintained
2 Apr 2025
JP Morgan
Jimmy Bhullar
56% 1-year accuracy
20 / 36 met price target
12%downside
$96
Neutral
Maintained
2 Apr 2025
Wells Fargo
Elyse Greenspan
54% 1-year accuracy
61 / 113 met price target
6%downside
$102
Equal-Weight
Maintained
19 Feb 2025

Financial journalist opinion

Based on 11 articles about AFL published over the past 30 days

Positive
Zacks Investment Research
8 hours ago
Aflac (AFL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Aflac (AFL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Aflac (AFL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Negative
Zacks Investment Research
8 hours ago
Aflac (AFL) Misses Q1 Earnings and Revenue Estimates
Aflac (AFL) came out with quarterly earnings of $1.66 per share, missing the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.66 per share a year ago.
Aflac (AFL) Misses Q1 Earnings and Revenue Estimates
Neutral
PRNewsWire
11 hours ago
Aflac Incorporated Announces First Quarter Results, Reports First Quarter Net Earnings of $29 Million, Declares Second Quarter Dividend
COLUMBUS, Ga. , April 30, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its first quarter results.
Aflac Incorporated Announces First Quarter Results, Reports First Quarter Net Earnings of $29 Million, Declares Second Quarter Dividend
Positive
Seeking Alpha
1 day ago
Best Dividend Aristocrats For May 2025
Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Edison (+25.65%), Cardinal Health (+17.82%), and Coca-Cola (+16.18%). 33 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.33%.
Best Dividend Aristocrats For May 2025
Positive
Zacks Investment Research
1 day ago
Aflac Gears Up for Q1 Earnings: Will AFL Quack or Crack?
AFL's first-quarter earnings are likely to have benefited from growing total adjusted revenues in Aflac U.S.
Aflac Gears Up for Q1 Earnings: Will AFL Quack or Crack?
Negative
Zacks Investment Research
1 day ago
What to Expect From These 4 Insurers This Earnings Season?
Strong premiums, M&A activities and tech efficiencies are likely to have aided insurers' Q1 performance, despite pressure from low interest rates, inflationary headwinds and catastrophe-related losses.
What to Expect From These 4 Insurers This Earnings Season?
Positive
Zacks Investment Research
5 days ago
Insights Into Aflac (AFL) Q1: Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Aflac (AFL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Insights Into Aflac (AFL) Q1: Wall Street Projections for Key Metrics
Positive
Zacks Investment Research
1 week ago
Aflac (AFL) Reports Next Week: Wall Street Expects Earnings Growth
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aflac (AFL) Reports Next Week: Wall Street Expects Earnings Growth
Neutral
PRNewsWire
1 week ago
9 in 10 Americans have put off health checkups and screenings that could help save their lives
Aflac Wellness Matters Survey uncovers what may be keeping Americans from getting preventive checkups COLUMBUS, Ga. , April 23, 2025 /PRNewswire/ -- April is National Cancer Prevention and Early Detection Month, a time to emphasize the importance of preventive health care and the value of early detection.
9 in 10 Americans have put off health checkups and screenings that could help save their lives
Positive
Zacks Investment Research
3 weeks ago
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Charts implemented using Lightweight Charts™